Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Onida

Showing results (271-280 of 351) with videos related to

Pageof 36
Sort By:
Haematologica|August 3, 2014
Impact of the International Prognostic Scoring System cytogenetic risk groups on the outcome of patients with primary myelodysplastic syndromes undergoing allogeneic stem cell transplantation from human leukocyte antigen-identical siblings: a retrospective analysis of the European Society for Blood and Marrow Transplantation-Chronic Malignancies Working PartyFrancesco Onida, Ronald Brand, Anja van Biezen, et al.
Blood|March 17, 2024
Management of adult patients with CMML undergoing allo-HCT: recommendations from the EBMT PH&G CommitteeFrancesco Onida, Nico Gagelmann, Yves Chalandon, et al.
Haematologica|October 16, 2012
Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter studyLivio Pagano, Caterina Giovanna Valentini, Alessandro Pulsoni, et al.
Bone Marrow Transplantation|March 27, 2023
Practice harmonization workshops of EBMT: an expert-based approach to generate practical and contemporary guidelines within the arena of hematopoietic cell transplantation and cellular therapyIbrahim Yakoub-Agha, Raffaella Greco, Francesco Onida, et al.
Bone Marrow Transplantation|April 26, 2020
Nilotinib in steroid-refractory cGVHD: prospective parallel evaluation of response, according to NIH criteria and exploratory response criteria (GITMO criteria)A Olivieri, G Mancini, J Olivieri, et al.
Transfusion|June 27, 2014
Should the standard dimethyl sulfoxide concentration be reduced? Results of a European Group for Blood and Marrow Transplantation prospective noninterventional study on usage and side effects of dimethyl sulfoxideCurly Morris, Liesbeth de Wreede, Marijke Scholten, et al.
BMJ Open|February 17, 2024
Evaluating pharmacological THRomboprophylaxis in Individuals undergoing superficial endoVEnous treatment across NHS and private clinics in the UK: a multi-centre, assessor-blind, randomised controlled trial-THRIVE trialMatthew Machin, Sarah Whittley, John Norrie, et al.
Haematologica|November 12, 2009
Prognostic impact of pre-transplantation transfusion history and secondary iron overload in patients with myelodysplastic syndrome undergoing allogeneic stem cell transplantation: a GITMO studyEmilio Paolo Alessandrino, Matteo Giovanni Della Porta, Andrea Bacigalupo, et al.
Bone Marrow Transplantation|April 9, 2025
Less frequent complications following CAR T-cell therapies: hemophagocytic lymphohistiocytosis, graft-versus-host disease, thrombotic microangiopathy, coagulation disorders and secondary malignancies: best practice recommendations from the EBMT Practice Harmonization and Guidelines CommitteeGuillermo Ortí, Guillaume Dachy, Charlotte E Graham, et al.
Journal of Crohn'S & Colitis|May 23, 2018
Autologous Haematopoietic Stem Cell Transplantation for Crohn's Disease: A Retrospective Survey of Long-term Outcomes From the European Society for Blood and Marrow TransplantationCharlotte K Brierley, Cristina Castilla-Llorente, Myriam Labopin, et al.
Pageof 36

Showing results (271-280 of 351) with videos related to

Sort By:
Pageof 36
Haematologica|August 3, 2014
Impact of the International Prognostic Scoring System cytogenetic risk groups on the outcome of patients with primary myelodysplastic syndromes undergoing allogeneic stem cell transplantation from human leukocyte antigen-identical siblings: a retrospective analysis of the European Society for Blood and Marrow Transplantation-Chronic Malignancies Working PartyFrancesco Onida, Ronald Brand, Anja van Biezen, et al.
Blood|March 17, 2024
Management of adult patients with CMML undergoing allo-HCT: recommendations from the EBMT PH&G CommitteeFrancesco Onida, Nico Gagelmann, Yves Chalandon, et al.
Haematologica|October 16, 2012
Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter studyLivio Pagano, Caterina Giovanna Valentini, Alessandro Pulsoni, et al.
Bone Marrow Transplantation|March 27, 2023
Practice harmonization workshops of EBMT: an expert-based approach to generate practical and contemporary guidelines within the arena of hematopoietic cell transplantation and cellular therapyIbrahim Yakoub-Agha, Raffaella Greco, Francesco Onida, et al.
Bone Marrow Transplantation|April 26, 2020
Nilotinib in steroid-refractory cGVHD: prospective parallel evaluation of response, according to NIH criteria and exploratory response criteria (GITMO criteria)A Olivieri, G Mancini, J Olivieri, et al.
Transfusion|June 27, 2014
Should the standard dimethyl sulfoxide concentration be reduced? Results of a European Group for Blood and Marrow Transplantation prospective noninterventional study on usage and side effects of dimethyl sulfoxideCurly Morris, Liesbeth de Wreede, Marijke Scholten, et al.
BMJ Open|February 17, 2024
Evaluating pharmacological THRomboprophylaxis in Individuals undergoing superficial endoVEnous treatment across NHS and private clinics in the UK: a multi-centre, assessor-blind, randomised controlled trial-THRIVE trialMatthew Machin, Sarah Whittley, John Norrie, et al.
Haematologica|November 12, 2009
Prognostic impact of pre-transplantation transfusion history and secondary iron overload in patients with myelodysplastic syndrome undergoing allogeneic stem cell transplantation: a GITMO studyEmilio Paolo Alessandrino, Matteo Giovanni Della Porta, Andrea Bacigalupo, et al.
Bone Marrow Transplantation|April 9, 2025
Less frequent complications following CAR T-cell therapies: hemophagocytic lymphohistiocytosis, graft-versus-host disease, thrombotic microangiopathy, coagulation disorders and secondary malignancies: best practice recommendations from the EBMT Practice Harmonization and Guidelines CommitteeGuillermo Ortí, Guillaume Dachy, Charlotte E Graham, et al.
Journal of Crohn'S & Colitis|May 23, 2018
Autologous Haematopoietic Stem Cell Transplantation for Crohn's Disease: A Retrospective Survey of Long-term Outcomes From the European Society for Blood and Marrow TransplantationCharlotte K Brierley, Cristina Castilla-Llorente, Myriam Labopin, et al.
Pageof 36